Singapore markets closed

electroCore, Inc. (ECOR)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
5.80+0.18 (+3.29%)
As of 12:52PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close5.62
Open5.59
Bid5.61 x 800
Ask5.99 x 800
Day's range5.59 - 5.95
52-week range3.10 - 7.50
Volume3,996
Avg. volume16,069
Market cap34.844M
Beta (5Y monthly)1.00
PE ratio (TTM)N/A
EPS (TTM)-4.11
Earnings date08 Nov 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est22.75
  • GlobeNewswire

    Dr. Peter Staats to Host Analyst Day on the Science Behind gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) on Tuesday, November 21, 2023

    ROCKAWAY, N.J., Nov. 15, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the Company’s Chief Medical Officer, Dr. Peter Staats will host an analyst day entitled “Accessing the Power of Vagus Nerve Stimulation with gammaCore™” on November 21, 2023 at 1:30pm EST. The webinar will cover the nVNS mechanism of action and potential pipeline of indications using the company’s proprietary nVNS technology plat

  • Insider Monkey

    electroCore, Inc. (NASDAQ:ECOR) Q3 2023 Earnings Call Transcript

    electroCore, Inc. (NASDAQ:ECOR) Q3 2023 Earnings Call Transcript November 8, 2023 electroCore, Inc. misses on earnings expectations. Reported EPS is $-0.68 EPS, expectations were $-0.64. Operator: Greetings, and welcome to the electroCore Third Quarter 2023 Earnings Conference Call. At this time, all participants on a listen only mode. Please make sure to mute yourself. A […]

  • GlobeNewswire

    electroCore Announces Third Quarter 2023 Financial Results

    Record third quarter 2023 net sales of $4.5 million, an increase of approximately 128% over third quarter 2022 Company increases revenue guidance for full year 2023 to $15.0 million - $15.5 million Company to host a conference call and webcast today, November 8, 2023 at 4:30 PM EST ROCKAWAY, N.J., Nov. 08, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company and wellness company, today announced third quarter 2023 financial results and prov